In mouse models of inflammation‐associated hepatocellular carcinoma, pharmacologic inhibition of NF‐κB restored apoptotic signaling in dysplastic hepatocytes and prevented progression to hepatocellular carcinoma, underscoring its causal role in survival signaling [77]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.